Feedback / Questions
CB-010 - Caribou Biosci
https://www.globenewswire.com/en/news-release/2024/09/03/2939617/0/en/Caribou-Biosciences-Announces-the-FDA-has-Granted-Fast-Track-Designations-to-CB-010-in-Refractory-SLE-and-to-CB-012-in-Relapsed-or-Refractory-AML.html
Sep 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next